FDA Seeks Input on Communicating Drug-Drug Interaction Information

As part of a continuing effort to address drug-drug interactions, the FDA’s Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will hold a meeting Sept. 25 to discuss strategies for the evaluation, interpretation and communication of drug-drug interaction information.
Washington Drug Letter